Table of Contents
PPT Slide
Forward-Looking Statements
VMS FY03 Profile
VMS Segments & Orders
Oncology Growth Drivers
Oncology Systems Products
Oncology Systems Products
Oncology Systems Products
Oncology Systems Products
Oncology Systems Products
Oncology Systems Products
IMRT: The Advantages
Five-Year Survival Rates For Prostate Cancer
Prostate Cancer: IMRT Lowers Complication Rates
IMRT Adoption Rate
The Radiotherapy Continuum
ACUITYThe first commercial cone beam CT product
Trilogy
INSPIRATIONThe only integrated system for all processes – SmartBeam IMRT and Dynamic Targeting IGRT
PPT Slide
X-Ray Products
Emerging Business Opportunities
Emerging Business Opportunities
FY03
Q1 FY04
BacklogRecord $850M(As of 01/02/04)
Q1 FY04 Balance Sheet / Cash Flow
Fiscal 2004 Outlook (As of end of First Quarter, Fiscal 2004)
PPT Slide
|